Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A

Journal of Clinical Pathology

Volumn 50, Issue 12, 1997, Pages 996-1000

  Vargas, S O ^a   Horensky, D ^a   Onderdonk, A B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clostridium difficile toxin; Cytotoxicity assay; enzyme immunoassay

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; TOXIN ANALYSIS;

EID: 0031441255     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.12.996     Document Type: Article

References (29)

1. Dodson AP, Borriello SP. Clostridium difficile infection of the gut. J Clin Pathol 1996;49:529-32.
2. Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacherl J, Bischof G, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995;95:2004-11.
3. Bongaerts GPA, Lyerly DM. Role of toxins A and B in the pathogenesis of Clostridium difficile disease. Microbial Pathogenesis 1994;17:1-12.
4. Barroso LA, Wang S-Z, Phelps CJ, Johnson JL, Wilkins TD. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res 1990;18:4004.
5. Dove CH, Wang S-Z, Phelps CJ, Lyerly DM, Wilkins TD, et al. Molecular characterisation of the Clostridium difficile toxin A gene. Infect Immun 1990;58:480-8.
6. Riederer KM, Lawson P, Held MS, Petrylka K, Briski LE, Khatib R. Diagnosis of Clostridium difficile associated diarrhea: comparison of three rapid methods employing different markers for detection. Can J Microbiol 1995;41:88-91.
7. Barbut F, Kaizer C, Planas N, Petit J-C. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium-difficile-associated diarrhea. J Clin Microbiol 1993;31:963-7.
8. Knapp CC, Sandin RL, Hall GS, Ludwig MD, Rutherford I, Washington JA. Comparison of vidas Clostridium difficile toxin-A assay and premier C. difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile. Diagn Microbiol Infect Dis 1993;17:7-12.
9. Mattia AR, Doern GV, Clark J, Holden J, Wu L, Ferraro MJ. Comparison of four methods in the diagnosis of Clostridium difficile disease. Eur J Clin Microbiol Infect Dis 1993;12:882-6.
10. Whittier S, Shapiro DS, Kelly WF, Walden P, Wait KJ, McMillon LT, et al. Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol 1993;31:2861-5.
11. Shanholtzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN, Peterson LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol 1992;30:1837-40.
12. Lyerly DM, Sullivan NM, Wilkins TD. Enzyme-linked imunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol 1983;17:72-8.
13. DeGirolami PC, Hanff PA, Eichelberger K, Longhi L, Teresa H, Pratt J, et al. Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A. J Clin Microbiol 1992;30:1085-8.
14. DiPersio JR, Varga FJ, Conwell DL, Kraft JA, Kozak KJ, Willis DH. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease. J Clin Microbiol 1991;29:2724-30.
15. Doern GV, Coughlin RT, Wu L. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoasay for taxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol 1992;30:2042-6.
16. Gilligan, PH, Walden TP, Kelly WF, Wait KJ, Kraft JA, Willis DH. The use of a commercially-available enzyme immunoassay for the detection of Clostridium difficile toxin A. Arch Pathol Lab Med 1993;117:507-10.
17. Knapp CC, Sandin RL, Hall GS, Ludwig MD, Rutherford I, Washington JA. Comparison of vidas Clostridium difficile toxin-A assay and premier C. difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile. Diagn Microbiol Infect Dis 1993;17:7-12.
18. Borriello SP, Vale T, Brazier JS, Hyde S, Chippeck E. Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A. Eur J Clin Microbiol 1992;11:360-3.
19. Delmee M, Mackey T, Hamilton A. Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools. Eur J Microbiol 1992;11:246-9.
20. Schue V, Green GA, Monteil H. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease. J Med Microbiol 1994;41:316-18.
21. Walker RC, Ruene PJ, Rosenblatt JE, Lyerly DM, Gleaves CA, Smith TF, et al. Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease. Diagn Microbiol Infect Dis 1986;5:61-9.
22. Johnson S, Sypura WD, Gerding DN, Ewing SL, Janoff EN. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun 1995;63:3166-73.
23. Torres JF, Monath TP. Antigenicity of amino-acid sequences from Clostridium difficile toxin B. J Med Microbiol 1996;44:464-74.
24. Warny M, Vaerman J-P, Avesany V, Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384-9.
25. Heerze LD, Kelm MA, Talbot JA, Armstrong GD. Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis. J Infect Dis 1994;169:1291-6.
26. Castagliuolo I, LaMont JT, Qui B, Nikulasson ST, Pothoulakis C. A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum. Gastroenterology 1996;111:433-8.
27. Taylor NS, Bartlett JG. Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis 1980;141:92-7.
28. Jensen GL, Bross JE, Bourbeau PP, Naumovitz DW, Streater M, Gianferante LE. Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. J Infect Dis 1994;170:227-30.
29. Watanakunakorn PW, Watanakunakorn C, Hazy J. Risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients: a case-control study sucralfate ingestion is not a negative risk factor. Infect Control Hosp Epidemiol 1996;17:212-5.